Basal ganglia metabolites (mM, mean (standard deviation)) | ||||
---|---|---|---|---|
 | Propionic Acidaemia | Normal MRI comparator group | ||
 | Metabolic stability (6 studies from 6 patients) | Acute encephalopathy (5 studies from 3 patients) | Post-liver transplant (2 studies from 2 patients) | (63 studies) |
Median age (years, (range)) | 3.6 (0.6-15.9) | 6.13 (1.0-9.4) | 14.4 (12.9-15.9) | 4.1 (0.5-16.7) |
N-Acetylaspartate | 5.03 (0.53) | 3.89 (0.20)†# | 5.35 (0.28) | 5.21 (0.51) |
Creatine | 4.57 (0.47) | 3.71 (0.58)†$ | 4.42 (0.14) | 4.55 (0.59) |
Glutamine | 1.29 (0.30) * | 1.00 (1.00)* | 1.27 (0.25) | 1.98 (0.79) |
Glutamate | 4.28 (0.25) | 3.07 (0.60)†# | 4.30 (0.39) | 4.45 (0.78) |
Glutamine+Glutamate | 5.57 (0.41) * | 4.07 (1.19)†$ | 5.57 (0.28) | 6.43 (1.39) |
myo-Inositol | 2.58 (0.26) | 2.79 (0.90) | 2.39 (0.0) | 2.49 (0.43) |
Lactate | 0.21 (0.25) | 0.93 (0.34)†# | 0.00 (0.32) | 0.11 (0.20) |
Choline | 1.10 (0.18) | 1.16 (0.29) | 0.90 (0.63) | 1.11 (0.18) |
White matter metabolites (mM, mean (standard deviation)) | ||||
 | Propionic Acidaemia | Normal MRI comparator group | ||
 | Metabolic stability (5 studies from 5 patients) | Acute encephalopathy (4 studies from 3 patients) | Post-liver transplant (2 studies from 2 patients) | (53 studies) |
Median age (years, (range)) | 3.1 (0.6-15.9) | 7.74 (3.0 -9.4) | 14.4 (12.9-15.9) | 4.7 (0.5-16.7) |
N-Acetylaspartate | 5.28 (0.80) | 4.50 (0.47) | 6.11 (0.39) | 5.11 (0.73) |
Creatine | 3.55 (0.19) * | 3.33 (0.53) | 3.70 (0.00) | 3.18 (0.47) |
Glutamine | 1.43 (0.54) | 1.34 (1.30) | 1.62 (0.49) | 1.32 (0.62) |
Glutamate | 3.83 (0.45) | 2.65 (0.44)*$ | 4.27 (0.31) | 3.51 (0.78) |
Glutamine+Glutamate | 5.26 (0.89) | 3.98 (1.54) | 5.89 (0.80) | 4.84 (1.18) |
myo-Inositol | 2.73 (0.31) | 2.57 (0.39) | 2.79 (0.02) | 2.57 (0.39) |
Lactate | 0.40 (0.30) | 0.81 (0.74)* | 0.32 (0.45) | 0.21 (0.28) |
Choline | 0.93 (0.15)* | 1.12 (0.37) | 0.83 (0.09) | 1.08 (0.15) |